<div id="readability-page-1">May 7 (Reuters) - Siemens Healthineers on Thursday cut its full year outlook to forecast revenue growth of between 4.5% and 5.0% for the 2026 financial year citing the structural change in the Chinese Diagnostics markets and more pronounced inflation assumptions during the quarter. The Chinese market accounts for around 10 percent of the company's total revenue with volume-based procurement and</div>

<p>西門子醫療已修訂其 2026 年的財務展望，現在預計收入增長為 4.5% 至 5.0%。這一調整歸因於中國診斷市場的結構性變化和通脹預期的上升。中國市場約佔公司總收入的 10%</p>

西門子醫療削減 2026 年預期